Owl Posting

How financial architectures shaped (and will continue to shape) Chinese drug development

4.5k words, 20 minutes reading time

May 11 • Abhishaike Mahajan

14

3

Perturb-MARS: Reading mouse experiments through a human lens

Multiplexed in-vivo perturbations, interpreted by a foundation model that has only ever seen human tumors.

Published on NOETIK • May 4

April 2026

Curious cases of financial engineering in biotech

7k words, 32 minutes reading time

Apr 27 • Abhishaike Mahajan

154

8

28

The printing press for biological data (Sterling Hooten)

2 hours listening time

Apr 20 • Abhishaike Mahajan

15

2

2:03:08

On creating 'new knobs of control' in biology

4.9k words, 22 minutes reading time

Apr 10 • Abhishaike Mahajan

87

8

14

March 2026

Owl Posting turns two

3.3k words, 15 minutes reading time

Mar 21 • Abhishaike Mahajan

34

3

3

Reasons to be pessimistic (and optimistic) on the future of biosecurity

13.2k words, 59 minutes reading time

Mar 16 • Abhishaike Mahajan

119

16

16

Neurotechnology? For Cancer? (Ben Woodington & Elise Jenkins)

1 hour and 33 minutes listening time

Mar 2 • Abhishaike Mahajan

13

1

1:33:19

February 2026

Heuristics for lab robotics, and where its future may go

8.4k words, 38 minutes reading time

Feb 9 • Abhishaike Mahajan

147

19

22

AI After Drug Development

Coming up with drug candidates isn’t the bottleneck on finding new treatments. Can AI help with the things that are?

Published on Asterisk Magazine  • Feb 2

January 2026

Questions to ask when evaluating neurotech approaches

5.2k words, 24 minutes reading time

Jan 25 • Abhishaike Mahajan

92

10

16

The truth behind the 2026 J.P. Morgan Healthcare Conference

2.8k words, 13 minutes reading time

Jan 12 • Abhishaike Mahajan

303

32

34